Thoratec was a surprise however the lack of any spike and a -5-10% drop is unwarranted. Again we seem content to fall on any positve news and hit the ground with bad news. Problem is shorts are less than 10% of total o/s. The real worry is the lack of buying even at these lows. 5 months ago we touched 7 now were at 2. Europe has been slow an average of 1-3 implants per quarter isnt progress. Need a turnaround fast.
Having thoratec as the seat observer doesnt mean they are the only interested party.
Most of us have been in denial for a while now but this has been very dissappointing.Hoping for the best but dilution at this range will be very bad.
- Forums
- ASX - By Stock
- Update US Study
Thoratec was a surprise however the lack of any spike and a...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online